Institution
United States Department of Veterans Affairs
Government•Washington D.C., District of Columbia, United States•
About: United States Department of Veterans Affairs is a government organization based out in Washington D.C., District of Columbia, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 61475 authors who have published 70990 publications receiving 3291429 citations. The organization is also known as: VA & Veterans Affairs Department.
Topics: Population, Poison control, Veterans Affairs, Health care, Receptor
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this article, the authors examined trends in thyroid cancer incidence, histology, size distribution, and mortality in the United States, concluding that the increasing incidence of thyroid cancer is primarily due to the increased detection of small papillary cancers.
Abstract: ContextIncreasing cancer incidence is typically interpreted as an increase in the true occurrence of disease but may also reflect changing pathological criteria or increased diagnostic scrutiny. Changes in the diagnostic approach to thyroid nodules may have resulted in an increase in the apparent incidence of thyroid cancer.ObjectiveTo examine trends in thyroid cancer incidence, histology, size distribution, and mortality in the United States.MethodsRetrospective cohort evaluation of patients with thyroid cancer, 1973-2002, using the Surveillance, Epidemiology, and End Results (SEER) program and data on thyroid cancer mortality from the National Vital Statistics System.Main Outcome MeasuresThyroid cancer incidence, histology, size distribution, and mortality.ResultsThe incidence of thyroid cancer increased from 3.6 per 100 000 in 1973 to 8.7 per 100 000 in 2002—a 2.4-fold increase (95% confidence interval [CI], 2.2-2.6; P .20 for trend). Virtually the entire increase is attributable to an increase in incidence of papillary thyroid cancer, which increased from 2.7 to 7.7 per 100 000—a 2.9-fold increase (95% CI, 2.6-3.2; P<.001 for trend). Between 1988 (the first year SEER collected data on tumor size) and 2002, 49% (95% CI, 47%-51%) of the increase consisted of cancers measuring 1 cm or smaller; 87% (95% CI, 85%-89%) consisted of cancers measuring 2 cm or smaller. Mortality from thyroid cancer was stable between 1973 and 2002 (approximately 0.5 deaths per 100 000).ConclusionsThe increasing incidence of thyroid cancer in the United States is predominantly due to the increased detection of small papillary cancers. These trends, combined with the known existence of a substantial reservoir of subclinical cancer and stable overall mortality, suggest that increasing incidence reflects increased detection of subclinical disease, not an increase in the true occurrence of thyroid cancer.
3,071 citations
••
TL;DR: Progress against CRC can be accelerated by increasing access to guideline‐recommended screening and high‐quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle‐aged adults.
Abstract: Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC occurrence based on incidence data (available through 2016) from population-based cancer registries and mortality data (through 2017) from the National Center for Health Statistics. In 2020, approximately 147,950 individuals will be diagnosed with CRC and 53,200 will die from the disease, including 17,930 cases and 3,640 deaths in individuals aged younger than 50 years. The incidence rate during 2012 through 2016 ranged from 30 (per 100,000 persons) in Asian/Pacific Islanders to 45.7 in blacks and 89 in Alaska Natives. Rapid declines in incidence among screening-aged individuals during the 2000s continued during 2011 through 2016 in those aged 65 years and older (by 3.3% annually) but reversed in those aged 50 to 64 years, among whom rates increased by 1% annually. Among individuals aged younger than 50 years, the incidence rate increased by approximately 2% annually for tumors in the proximal and distal colon, as well as the rectum, driven by trends in non-Hispanic whites. CRC death rates during 2008 through 2017 declined by 3% annually in individuals aged 65 years and older and by 0.6% annually in individuals aged 50 to 64 years while increasing by 1.3% annually in those aged younger than 50 years. Mortality declines among individuals aged 50 years and older were steepest among blacks, who also had the only decreasing trend among those aged younger than 50 years, and excluded American Indians/Alaska Natives, among whom rates remained stable. Progress against CRC can be accelerated by increasing access to guideline-recommended screening and high-quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle-aged adults.
2,928 citations
•
01 Jan 2005TL;DR: Haug, Sorensen, Gruber, Song, Relapse Prevention for Opioid Dependence, and Wheeler, George, Stoner, Enhancing the Relapse prevention model for Sex Offenders: Adding Recidivism Risk Reduction Therapy to Target Offenders' Dynamic Risk Needs.
Abstract: Marlatt, Witkiewitz, Relapse Prevention for Alcohol and Drug Problems. Blume, de la Cruz, Relapse Prevention among Diverse Populations. Kadden, Cooney, Treating Alcohol Problems. Shiffman, Kassel, Gwaltney, McChargue, Relapse Prevention for Smoking. Carroll, Rawson, Relapse Prevention for Stimulant Dependence. Haug, Sorensen, Gruber, Song, Relapse Prevention for Opioid Dependence. Roffman, Stephens, Relapse Prevention for Cannabis Abuse and Dependence. Kilmer, Cronce, Palmer, Relapse Prevention for Abuse of Club Drugs, Hallucinogens, Inhalants, and Steroids. Collins, Relapse Prevention for Eating Disorders and Obesity. Shaffer, LaPlante, Treatment of Gambling Disorders. Wheeler, George, Stoner, Enhancing the Relapse Prevention Model for Sex Offenders: Adding Recidivism Risk Reduction Therapy to Target Offenders' Dynamic Risk Needs. Zawacki, Stoner, George, Relapse Prevention for Sexually Risky Behaviors.
2,866 citations
••
TL;DR: An understanding of the complex pathways of sphingolipid metabolism and the mechanisms that regulate lipid generation and lipid action is required to understand the mechanisms of cell growth, death, senescence, adhesion, migration, inflammation, angiogenesis and intracellular trafficking.
Abstract: It has become increasingly difficult to find an area of cell biology in which lipids do not have important, if not key, roles as signalling and regulatory molecules. The rapidly expanding field of bioactive lipids is exemplified by many sphingolipids, such as ceramide, sphingosine, sphingosine-1-phosphate (S1P), ceramide-1-phosphate and lyso-sphingomyelin, which have roles in the regulation of cell growth, death, senescence, adhesion, migration, inflammation, angiogenesis and intracellular trafficking. Deciphering the mechanisms of these varied cell functions necessitates an understanding of the complex pathways of sphingolipid metabolism and the mechanisms that regulate lipid generation and lipid action.
2,856 citations
Authors
Showing all 61503 results
Name | H-index | Papers | Citations |
---|---|---|---|
Robert J. Lefkowitz | 214 | 860 | 147995 |
Rob Knight | 201 | 1061 | 253207 |
Irving L. Weissman | 201 | 1141 | 172504 |
Ronald M. Evans | 199 | 708 | 166722 |
Robert M. Califf | 196 | 1561 | 167961 |
Eric J. Topol | 193 | 1373 | 151025 |
Nicholas G. Martin | 192 | 1770 | 161952 |
Stephen V. Faraone | 188 | 1427 | 140298 |
Gordon B. Mills | 187 | 1273 | 186451 |
Scott M. Grundy | 187 | 841 | 231821 |
Paul G. Richardson | 183 | 1533 | 155912 |
Dennis S. Charney | 179 | 802 | 122408 |
Bruce M. Spiegelman | 179 | 434 | 158009 |
Kenneth C. Anderson | 178 | 1138 | 126072 |
Kenneth S. Kendler | 177 | 1327 | 142251 |